fda 503a bulks list category 2 bpc 157 FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the compounding now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them BPC-157 just got voted in

BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting I just testified at an FDA meeting on whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's FDA commitee votes 8 6 to make BPC 157 legal. What the FDA briefing report said about the evidence. Empirical Health

SKU: 85801739255 · From creatorsinfotech.com